EU should buy patent rights for COVID-19 tests, says Greece
07-04-2020
Costa Rica asks WHO to create voluntary COVID-19 IP pool
26-03-2020
Piotr Swat / Shutterstock.com
Israel has approved generic versions of an HIV antiviral owned by AbbVie for use in treating coronavirus, despite the company still holding patent protection and doubts over its effectiveness.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
COVID-19, AbbVie, HIV, coronavirus, antiviral, Israel, lopinavir-ritonavir, Kaletra, New England Journal of Medicine
